Indiana · 2026 Regular Session · Bill
HB 1087: Overdose reversal medication.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1087 is a bill introduced in the Indiana House on January 5, 2026. According to its official title, it concerns: Overdose reversal medication. Primary sponsor: Mike Andrade (Democratic). It lists 2 additional sponsors. Most recent recorded action (January 5, 2026): First reading: referred to Committee on Public Health.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Provides that, subject to available funding, the division of mental health and addiction may develop an application to provide funds to a school corporation or school maintained by a school corporation to obtain a federal Food and Drug Administration approved opioid overdose reversal medication. Provides that the state health commissioner shall issue a statewide standing order, prescription, or protocol for a federal Food and Drug Administration approved opioid overdose reversal medication for each public school or school corporation.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mike Andrade | Primary sponsor | Democratic | House | 12 |
| Garrett Bascom | Co-sponsor | Republican | House | 68 |
| Tonya Pfaff | Co-sponsor | Democratic | House | 43 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- First reading: referred to Committee on Public Health
- Authored by Representative Andrade
- Coauthored by Representatives Bascom, Pfaff